Quick Answer
CORCEPT THERAPEUTICS INC reported Stockholders Equity of $647.81 million for the year ending 2025.
- CORCEPT THERAPEUTICS INC showed a decrease of -4.7% in Stockholders Equity from 2024 to 2025.
- This data is from CORCEPT THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $9.37 million | Q2 2014: $3.45 million | Q3 2014: -$1.32 million | Q1 2015: $10.57 million | Q2 2015: $11.53 million | Q3 2015: $13.48 million | Q1 2016: $20.17 million | Q2 2016: $25.66 million | Q3 2016: $31.25 million | Q1 2017: $49.58 million | Q2 2017: $66.15 million | Q3 2017: $86.30 million | Q1 2018: $215.23 million | Q2 2018: $243.51 million | Q3 2018: $259.55 million | Q1 2019: $285.76 million | Q2 2019: $298.05 million | Q3 2019: $334.38 million | Q1 2020: $409.49 million | Q2 2020: $453.70 million | Q3 2020: $489.68 million | Q1 2021: $510.80 million | Q2 2021: $522.68 million | Q3 2021: $540.23 million | Q1 2022: $407.81 million | Q2 2022: $442.33 million | Q3 2022: $473.36 million | Q1 2023: $529.58 million | Q2 2023: $421.61 million | Q3 2023: $461.68 million | Q1 2024: $547.86 million | Q2 2024: $596.24 million | Q3 2024: $638.84 million | Q1 2025: $683.29 million | Q2 2025: $635.79 million | Q3 2025: $631.90 million.
- Over the full 14 years of available data (2012 to 2025), CORCEPT THERAPEUTICS INC's Stockholders Equity has grown by 948.6%.
- Historical annual values: Fiscal year 2025: $647.81 million | Fiscal year 2024: $679.59 million | Fiscal year 2023: $506.71 million | Fiscal year 2022: $501.84 million | Fiscal year 2021: $375.81 million | Fiscal year 2020: $523.34 million | Fiscal year 2019: $371.18 million | Fiscal year 2018: $275.88 million | Fiscal year 2017: $190.97 million | Fiscal year 2016: $41.38 million | Fiscal year 2015: $18.50 million | Fiscal year 2014: -$3.39 million | Fiscal year 2013: $21.02 million | Fiscal year 2012: $61.78 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: